COPD patients with severe diffusion defect in carbon monoxide diffusing capacity predict a better outcome for pulmonary rehabilitation

Revista Portuguesa de Pneumologia (English Edition)

Volumn 22, Issue 6, 2016, Pages 323-330

  Sahin, H ^a   Naz, I ^b   Varol, Y ^a   Aksel, N ^a   Tuksavul, F ^a   Ozsoz, A ^a  

^a Dr Suat Seren Chest Diseases and Thoracic Surgery Research and Training Hospital   (Turkey)

^b IZMIR KATIP CELEBI UNIVERSITY   (Turkey)

Author keywords

6 Minute walk test; DLCO; Dyspnea; Pulmonary function tests; Pulmonary rehabilitation; Quality of life

Indexed keywords

CARBON MONOXIDE;

ADULT; AGED; ARTICLE; BLOOD GAS ANALYSIS; CHRONIC OBSTRUCTIVE LUNG DISEASE; COHORT ANALYSIS; DIAGNOSTIC TEST; DYSPNEA; EXERCISE; FEMALE; HUMAN; LUNG DIFFUSION CAPACITY; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PROSPECTIVE STUDY; PULMONARY REHABILITATION; QUESTIONNAIRE; SIX MINUTE WALK TEST; LUNG FUNCTION TEST; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; PREDICTIVE VALUE; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

AGED; CARBON MONOXIDE; FEMALE; HUMANS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; PULMONARY DIFFUSING CAPACITY; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RESPIRATORY FUNCTION TESTS; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 85006054219     PISSN: None     EISSN: 21735115     Source Type: Journal    
DOI: 10.1016/j.rppnen.2016.03.003     Document Type: Article

References (45)

1. Santus P, Bassi L, Radovanovic D, Airoldi A, Raccanelli R, Triscari F, et al. Pulmonary rehabilitation in COPD: a reappraisal (2008-2012). Pulm Med. 2013;2013:374283
2. Bailey KL. The importance of the assessment of pulmonary function in COPD. Med Clin North Am. 2012;96:745-52
3. Spruit M, Singh S, Garvey C, ZuWallack R, Nici L, Rochester C, et al. An Official American Thoracic Society/European Respiratory Society Statement: key concepts and advances in pulmonary rehabilitation. Am J Respir Crit Care Med. 2013;188:13-64
4. Luxton N, Alison JA, Wu J, Mackey MG. Relationship between field walking test and incremental cycle ergometry in COPD. Respirology. 2008;13:856-62
5. Lan CC, Chu WH, Yang MC, Lee CH, Wu YK, Wu CP. Benefits of pulmonary rehabilitation in patients with COPD and normal exercise capacity. Respir Care. 2013;58:1482-8
6. Karapolat H, Gürgün A, Eyigör S, Ekren PK, Kirazlı Y. Effect of short-term pulmonary rehabilitation on pulmonary function tests, blood gases, functional capacity, dyspnea, quality of life and psychological symptoms in chronic pulmonary diseases: a retrospective study. Turk J Phys Med Rehabil. 2010;56:6-10
7. Karapolat H, Atasever A, Atamaz F, Kirazli Y, Elmas F, Erdinç E. Do the benefits gained using a short-term pulmonary rehabilitation program remain in COPD patients after participation. Lung. 2007;185:221-5
8. Román M, Larraz C, Gómez A, Ripoll J, Mir I, Miranda EZ, et al. Efficacy of pulmonary rehabilitation in patients with moderate chronic obstructive pulmonary disease: a randomized controlled trial. BMC Fam Pract. 2013;11:14-21
9. Hughes JMB. The single breath transfer factor (TL CO) and the transfer coefficient (KCO): a window onto the pulmonary microcirculation. Clin Physiol Funct Imaging. 2003;23:63-71
10. Miniati M, Monti S, Pavlickova I, Bottai M. Survival in COPD: impact of lung dysfunction and comorbidities. Medicine (Baltimore). 2014;93:76
11. Farkhooy A, Janson C, Arnardóttir RH, Malinovschi A, Emtner M, Hedenström H. Impaired carbon monoxide diffusing capacity is the strongest predictor of exercise intolerance in COPD. COPD. 2013;10:180-5
12. Quenjer PH, Tammeling GJ, Cotes JE, Pedersen OF, Peslin R, Yernault JC. Lung volumes and forced ventilatory flows. Report working party standardization of lung function tests, European community for steel and coal. Official statement of European Respiratory Society. Eur Respir J Suppl. 1993;16:5-40
13. GOLD Executive Committee. Global strategy for diagnosis, management and prevention of COPD [updated 2009; accessed 2010 July 1]. Available from: http://www.golcopd.com
14. Pellegrino R, Viegi G, Brusasco V, Crapo RO, Burgos F, Casaburi R, et al. Interpretative strategies for lung function tests. Eur Respir J. 2005;26:948-68
15. Polatlı M, Yorgancıoğlu A, Aydemir Ö, Yılmaz DN, Kırkıl G, Atı¸ Naycı S, et al. Validity and reliability of Turkish version of St. George’s respiratory questionnaire. Tuberc Torax. 2013;61:81-7
16. Koçyiğit H, Aydemir Ö, Fisek G, Ölmez N, Memis A. Validity and reliability of Turkish version of Short form SF-36. Turk J Drugs Therapeut. 1999;12:102-6
17. Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983;67:361-70
18. Aydemir Ö. Hastane Anksiyete ve Depresyon Ölçeği Türkçe formunun geçerlilik ve güvenilirlik çalıması. Türk Psikiyatri Dergisi. 1997;8:280-7
19. ATS statement: guidelines for the six-minute walk test. Am J Respir Care Med. 2002;166:111-7
20. ATS/ERS statement on Pulmonary Rehabilitation. Am J Respir Cirit Care Med. 2006:390-413
21. Sahin HD, Naz I, Aksel N, Demir A, Tuksavul F, Ozsoz A. Outcomes of pulmonary physiotherapy and rehabilitation program applied to patients with chronic pulmonary disease. Turkiye Klinikleri Arch Lung. 2014;15:47-53
22. Zanini A, Chetta A, Gumiero F, Patrona SD, Casale S, Zampogna E, et al. Six-minute walking distance improvement after pulmonary rehabilitation is associated with baseline lung function in complex COPD patients: a retrospective study. BioMed Res Int. 2013:483-162
23. Boutou AK, Shrikrishna D, Tanner RJ, Smith C, Kelly JL, Ward SP, et al. Lung function indices for predicting mortality in COPD. Eur Respir J. 2013;42:616-25
24. Farkhooy A, Janson C, Arnardóttir RH, Emtner M, Hedenström H, Malinovschi A. Impaired carbon monoxide diffusing capacity is the strongest lung function predictor of decline in 12 minute-walking distance in COPD; a 5-year follow-up study. COPD. 2014;10 [epub ehead of print]
25. Osmanliev DP, Joyce H, Watson RA, Pride NB. Evolution of changes in carbon monoxide transfer factor in men with chronic obstructive pulmonary disease. Respir Med. 2005;99: 1053-60
26. Mohamed Hoesein FA, Zanen P, van Ginneken B, van Klaveren RJ, Lammers JW. Association of the transfer coefficient of the lung for carbon monoxide with emphysema progression in male smokers. Eur Respir J. 2011;38:1012-8
27. Mohsenifar Z, Lee SM, Diaz P, Criner G, Sciurba F, Ginsburg M, et al. Single-breath diffusing capacity of the lung for carbon monoxide: a predictor of PaO2, maximum work rate, and walking distance in patients with emphysema. Chest. 2003;123:1394-400
28. Ries AL. Pulmonary rehabilitation: summary of an evidencebased guideline. Respir Care. 2008;53:1203-7
29. Marciniuk DD, Brooks D, Butcher S, Debigare R, Dechman G, Ford G, et al. Optimizing pulmonary rehabilitation in chronic obstructive pulmonary disease practical issues: a Canadian Thoracic Society Clinical Practice Guideline. Can Respir J. 2010;17:159-68
30. Gloeckl R, Marinov B, Pitta F. Practical recommendations for exercise training in patients with COPD. Eur Respir Rev. 2013;22:178-86
31. Nici L, Donner C, Wouters E, Zuwallack R, Ambrosino N, Bourbeau J, et al. American Thoracic Society/European Respiratory Society statement on pulmonary rehabilitation. Am J Respir Crit Care Med. 2006;173:1390-413
32. Rochester CL. Exercise training in chronic obstructive pulmonary disease. J Rehabil Res Dev. 2003;40:59-80
33. Katiyar SK, Bihari S. Role of Pranayama in Rehabilitation of COPD patients a Randomized Controlled Study. Indian J Allergy Asthma Immunol. 2006;20:98-104
34. Cecily HSJ, Alotaibi AA. Effectiveness of breathing exercises on pulmonary function parameters and quality of life of patients with chronic obstructive pulmonary disease. IJHSR. 2013;3:80-5
35. Shebl A, Fadila D. Impact of pulmonary rehabilitation program on health outcomes of patients with chronic obstructive pulmonary disease. J Educ Pract. 2013;4:78-86
36. Emery CF, Leatherman NE, Burker EJ, MacIntyre NR. Psychological outcomes of a pulmonary rehabilitation program. Chest. 1991;100:613-7
37. Takigawa N, Tada A, Soda R, Takahashi S, Kawata N, Shibayama T, et al. Comprehensive pulmonary rehabilitation according to severity of COPD. Respir Med. 2007;101:326-32
38. Stav D, Raz M, Shpirer I. Three years of pulmonary rehabilitation: inhibit the decline in airflow obstruction, improves exercise endurance time, and body-mass index, in chronic obstructive pulmonary disease. BMC Pulm Med. 2009;30:9-26
39. Sarpkaya U, Tuna H, Tabakoglu E, Altıay G. Effects of ventilatory muscle training and aerobic exercise program in chronic obstructive pulmonary disease on quality of life. Turk J Phys Med Rehab. 2005;51:14-8
40. Vagaggini B, Costa F, Antonelli S, Simone CD, Cusatis GD, Martino F, et al. Clinical predictors of the efficacy of a pulmonary rehabilitation programme in patients with COPD. Respir Med. 2009;103:1224-30
41. Altenburg WA, De Greef MH, ten Hacken NH, Wempe JB. A better response in exercise capacity after pulmonary rehabilitation in more severe COPD patients. Respir Med. 2012;106:694-700
42. Macintyre N, Crapo RO, Viegi G, Jhonson DC, van der Griten CPM, Brusasco V, et al. Standardisation of the single-breath determination of carbon monoxide uptake in the lung. Eur Respir J. 2005;26:720
43. Mccormack MC. Diffusing capacity for carbon monoxide. Up-todate. Last updated July 16; 2015
44. AACVPR guidelines for pulmonary rehabilitation programmes. 3rd ed. Human Kinetics; 2005
45. Garrod R, Marshall J, Barley E, Jones PW. Predictors of success and failure in pulmonary rehabilitation. Eur Respir J. 2006;27:788-94